Alzheimer’s Disease: New Beginnings

Select Content Type
eBooks
Authored By
G. Perry, J. Avila, P.I. Moreira, G. Perry, J. Avila, P.I. Moreira
Authored On
Interests
Neurology
Speciality
Neurology
Book Detail
volume
00006
ISSN
9781614998754
Publication Date
Actions
Download in App
Banner image
Cover Image
Event Data
{"title":"Alzheimer\u2019s Disease: New Beginnings","subtitle":"","e_issn":null,"url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=e600tww&AN=1473162&site=ehost-live&scope=site","series":"Advances in Alzheimer's Disease","edition":"","author":"Perry, George-IOS Press","contract_publisher":"","imprint_publisher":"IOS Press","pub_year":"2018","interest_area":["Neurology"],"lcc":"RC523 .A49 2018","lcsh":"Alzheimer's disease.","language":"eng","format":"PDF","downloadable":"TRUE","fiction":"FALSE","abridged":"","book_id":"1876779","isbn":"9781614998754","eisbn":"9781614998761","ocn":"1049711912","ddc":"616.8\/311","isPdfLink":false,"isSAML":true,"an":"1473162","number_other":"","type_pub":"","isbn_print":"9781451191462","isbn_electronic":"9781496320773","languages":"English","date_entry":"","date_update":"","doi":"","titleSource":"","date_pub_cy":"","type_document":"","volume":null,"issue":null,"authored_on":"2018-01-01","description":"Alzheimer's Disease: New Beginnings focuses on the future promise for therapeutic breakthroughs in light of notable clinical trial failures. The volume editors used a combination of scientometric evaluations to determine the most promising new approaches as well as soliciting insights from leaders in each of the major areas of Alzheimer's disease research. By combining these two approaches, they recruited authors from the entire outlook spectrum, from those who feel an elusive breakthrough might still be a few, well-placed tweaks away to those who feel that they are launching entirely new investigative paradigms. These scholars present an open-eyed path forward. Now is the most exciting period in this field as old dogmas make way for new insights, from new approaches to clinical trials, improved biomarker-based diagnostics, population-based studies, prevention, metabolism, to further refinement of the role of inflammation, genetics, tau, and amyloid-\u03b2.","publication_date":"2016-01-01","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=nlebk&AN=1876779&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Sam D. Graham, Thomas E. Keane, Sam D. Graham, Thomas E. Keane","header":{"DbId":"nlebk","DbLabel":"eBook Collection (EBSCOhost)","An":"1876779","RelevancyScore":"1084","PubType":"eBook","PubTypeId":"ebook","PreciseRelevancyScore":"1083.55249023438"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=nlebk&AN=1876779&authtype=shib&custid=ns346513&group=main&profile=eds","additionalInfo":{"Authored_By":"G. Perry, J. Avila, P.I. Moreira, G. Perry, J. Avila, P.I. Moreira","Categories":"MEDICAL \/ Neuroscience","Subjects":"Alzheimer's disease","Electronic_ISBN":"9781614998761","Print_ISBN":"9781614998754","Languages":"English","Published_Date":"2018-01-01","Resource_Type":"eBook.","Title_Abbreviations":"Alzheimer\u2019s Disease: New Beginnings","Volume":"00006"}}
ISSN
9781614998754
IS_Ebsco
true
Additional Info
["G. Perry, J. Avila, P.I. Moreira, G. Perry, J. Avila, P.I. Moreira","MEDICAL \/ Neuroscience","Alzheimer's disease","9781614998761","9781614998754","English","2018-01-01","eBook.","Alzheimer\u2019s Disease: New Beginnings","00006"]
Description
Alzheimer's Disease: New Beginnings focuses on the future promise for therapeutic breakthroughs in light of notable clinical trial failures. The volume editors used a combination of scientometric evaluations to determine the most promising new approaches as well as soliciting insights from leaders in each of the major areas of Alzheimer's disease research. By combining these two approaches, they recruited authors from the entire outlook spectrum, from those who feel an elusive breakthrough might still be a few, well-placed tweaks away to those who feel that they are launching entirely new investigative paradigms. These scholars present an open-eyed path forward. Now is the most exciting period in this field as old dogmas make way for new insights, from new approaches to clinical trials, improved biomarker-based diagnostics, population-based studies, prevention, metabolism, to further refinement of the role of inflammation, genetics, tau, and amyloid-β.
Published Date